21.50
Schlusskurs vom Vortag:
$21.55
Offen:
$21.53
24-Stunden-Volumen:
537.57K
Relative Volume:
0.19
Marktkapitalisierung:
$2.11B
Einnahmen:
$221.08M
Nettoeinkommen (Verlust:
$-2.92M
KGV:
-651.67
EPS:
-0.033
Netto-Cashflow:
$5.89M
1W Leistung:
-0.39%
1M Leistung:
+0.73%
6M Leistung:
+144.10%
1J Leistung:
+95.50%
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
Firmenname
Avadel Pharmaceuticals Plc
Sektor
Telefon
636-449-1830
Adresse
10 EARLSFORT TERRACE, DUBLIN 2
Vergleichen Sie AVDL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
AVDL
Avadel Pharmaceuticals Plc
|
21.50 | 2.11B | 221.08M | -2.92M | 5.89M | -0.033 |
|
ZTS
Zoetis Inc
|
125.47 | 55.45B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.62 | 49.25B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.01 | 45.02B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.62 | 35.81B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
492.15 | 20.98B | 3.08B | 1.24B | 1.07B | 25.61 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-23 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-09-03 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-07-18 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-02-11 | Eingeleitet | Deutsche Bank | Buy |
| 2024-06-12 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-03-05 | Bestätigt | H.C. Wainwright | Buy |
| 2024-03-05 | Bestätigt | Needham | Buy |
| 2024-03-05 | Bestätigt | Oppenheimer | Outperform |
| 2024-02-06 | Eingeleitet | UBS | Buy |
| 2022-11-30 | Hochstufung | Jefferies | Hold → Buy |
| 2022-08-10 | Herabstufung | Jefferies | Buy → Hold |
| 2022-07-28 | Fortgesetzt | Craig Hallum | Buy |
| 2022-05-26 | Herabstufung | Stifel | Buy → Hold |
| 2021-09-23 | Eingeleitet | Needham | Buy |
| 2020-07-31 | Eingeleitet | Oppenheimer | Outperform |
| 2020-07-21 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-04-03 | Eingeleitet | Jefferies | Buy |
| 2020-03-12 | Eingeleitet | Stifel | Buy |
| 2020-02-26 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-30 | Eingeleitet | Craig Hallum | Buy |
| 2019-06-14 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2019-02-08 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
Alle ansehen
Avadel Pharmaceuticals Plc Aktie (AVDL) Neueste Nachrichten
BlackRock discloses 6.75% stake in Avadel Pharmaceuticals - Investing.com
Form 8.3Avadel Pharmaceuticals plc - The Manila Times
Bank of America discloses 2.38% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Canada
Bank of America discloses 2.38% stake in Avadel Pharmaceuticals - Investing.com
Goldman Sachs discloses minor stake in Avadel Pharmaceuticals By Investing.com - Investing.com South Africa
Goldman Sachs discloses minor stake in Avadel Pharmaceuticals - Investing.com
10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
REGGeode Capital Mgmnt Avadel Pharma plcForm 8.3Avadel Pharmaceuticals plc - TradingView — Track All Markets
Morgan Stanley&CoLLCRule 38.5_AAvadel Pharmaceuticals plc - Research Tree
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares By Investing.com - Investing.com Nigeria
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares By Investing.com - Investing.com Nigeria
Geode Capital discloses 2.2% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Morgan Stanley & Co.Rule 38.5_AAvadel Pharmaceuticals plc - Research Tree
Goldman Sachs & Co.38.5b-Avadel Pharmaceuticals PLC - Research Tree
Bank of America discloses 2.39% stake in Avadel Pharmaceuticals - Investing.com
Avadel Pharmaceuticals PLC. (NASDAQ:AVDL) Sees Large Drop in Short Interest - MarketBeat
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares - Investing.com
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares - Investing.com
Morgan Stanley discloses trades in Avadel Pharmaceuticals shares By Investing.com - Investing.com Nigeria
Precision Trading with Avadel Pharmaceuticals Plc (AVDL) Risk Zones - Stock Traders Daily
Goldman Sachs (EPT)ITP Only(38.5bAvadel Pharmaceuticals PLC) - Research Tree
Bank of America discloses 2.37% stake in Avadel Pharmaceuticals - Investing.com
Goldman Sachs discloses trading position in Avadel Pharmaceuticals By Investing.com - Investing.com Australia
Morgan Stanley discloses trades in Avadel Pharmaceuticals shares - Investing.com
Goldman Sachs discloses trading position in Avadel Pharmaceuticals - Investing.com
Bank of America discloses 2.1% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Morgan Stanley Europe SE reports Avadel Pharmaceuticals dealings By Investing.com - Investing.com Nigeria
Janus Henderson discloses 1.89% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Janus Henderson discloses 1.89% stake in Avadel Pharmaceuticals - Investing.com
Bank of America discloses 2.1% stake in Avadel Pharmaceuticals - Investing.com
JP Morgan Sec LLCForm 38.5B(EPT/NON-RI)-Avadel Pharmaceuticals plc - Research Tree
Morgan StanleyEuropeRule 38.5_BAvadel Pharmaceuticals plc - Research Tree
Morgan Stanley Europe SE reports Avadel Pharmaceuticals dealings - Investing.com
Bank of America discloses 2.17% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Citadel Group discloses 1.09% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
J.P. Morgan discloses trading in Avadel Pharmaceuticals amid takeover By Investing.com - Investing.com Nigeria
Finanzdaten der Avadel Pharmaceuticals Plc-Aktie (AVDL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Avadel Pharmaceuticals Plc-Aktie (AVDL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Thornton Peter J. | Director |
Jan 13 '25 |
Buy |
8.04 |
10,000 |
80,450 |
104,055 |
| Ende Eric J | Director |
Jan 13 '25 |
Buy |
7.84 |
30,000 |
235,218 |
208,900 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):